Reducing methamphetamine use in young people
Investigator: Dr Gillinder Bedi
There is a lack of effective options for treating methamphetamine use problems in young people.
Although psychological treatments are effective, relapse rates are high. Effective medication options are needed to improve treatment outcomes.
This study will identify young people who may be eligible to take part in one or more Orygen studies testing potential new medications for reducing methamphetamine use.
What does the study involve?
The Methamphetamine Treatment Studies Screening Protocol aims to identify young people who may be eligible to take part in Orygen studies testing potential new medications for reducing methamphetamine use.
To work out if one of Orygen’s treatment studies is the right fit, participants will be required to attend appointments in Parkville, Werribee, Sunshine, Craigieburn, Glenroy or Melton (depending on which is most convenient). They will complete a medical check-up including some tests (urine, blood and breath samples) and will be asked questions about their drug use, health, and mental health. This will take up to 3–4 hours and can be done over up to three visits.
These assessments will be used to see if participants are eligible to take part in one of Orygen’s clinical trials testing potential medications for methamphetamine use problems.
Participants will be reimbursed for their time and for expenses they incur in order to take part in the study, such as parking or transport costs.
To be eligible participants must be aged between 15 and 25 years and:
- currently use methamphetamine (‘ice’ or ‘speed’)
- be interested in receiving treatment to reduce methamphetamine use.
Participation in the study is completely voluntary and Orygen researchers will ensure participants have all information about the study before they provide consent.
Young people who are interested in participating in the study should complete the form below.
This study as been approved by Melbourne Health HREC (HREC/65565/MH-2020)